Cargando…

Cross-lineage protection by human antibodies binding the influenza B hemagglutinin

Influenza B viruses (IBV) drive a significant proportion of influenza-related hospitalisations yet are understudied compared to influenza A. Current vaccines target the head of the viral hemagglutinin (HA) which undergoes rapid mutation, significantly reducing vaccine effectiveness. Improved vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yi, Tan, Hyon-Xhi, Koutsakos, Marios, Jegaskanda, Sinthujan, Esterbauer, Robyn, Tilmanis, Danielle, Aban, Malet, Kedzierska, Katherine, Hurt, Aeron C., Kent, Stephen J., Wheatley, Adam K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6338745/ https://www.ncbi.nlm.nih.gov/pubmed/30659197 http://dx.doi.org/10.1038/s41467-018-08165-y

Ejemplares similares

Subdominance and poor intrinsic immunogenicity limit humoral immunity targeting influenza HA stem
por: Tan, Hyon-Xhi, et al.
Publicado: (2019)

Uncomplicated Cystitis in an Adult Male Following Influenza B Virus Infection
por: Allen, Robert J., et al.
Publicado: (2017)

Robust immunity to influenza vaccination in haematopoietic stem cell transplant recipients following reconstitution of humoral and adaptive immunity
por: Zhang, Wuji, et al.
Publicado: (2023)

Influenza antivirals currently in late‐phase clinical trial
por: Koszalka, Paulina, et al.
Publicado: (2017)

Influenza lineage extinction during the COVID-19 pandemic?
por: Koutsakos, Marios, et al.
Publicado: (2021)

Inducible Bronchus-Associated Lymphoid Tissues (iBALT) Serve as Sites of B Cell Selection and Maturation Following Influenza Infection in Mice
por: Tan, Hyon-Xhi, et al.
Publicado: (2019)

The Potential Role of Fc-Receptor Functions in the Development of a Universal Influenza Vaccine
por: Jegaskanda, Sinthujan
Publicado: (2018)

Prime-boost, double-dose influenza vaccine immunity in COPD: a pilot observational study
por: Anderson, Gary P., et al.
Publicado: (2023)

Sequencing B cell receptors from ferrets (Mustela putorius furo)
por: Wong, Julius, et al.
Publicado: (2020)

Viral burden, inflammatory milieu and CD8(+) T‐cell responses to influenza virus in a second‐generation thiazolide (RM‐5061) and oseltamivir combination therapy study
por: Nüssing, Simone, et al.
Publicado: (2020)

The ABC of Major Histocompatibility Complexes and T Cell Receptors in Health and Disease
por: Kedzierska, Katherine, et al.
Publicado: (2020)

Robust and prototypical immune responses toward influenza vaccines in the high-risk group of Indigenous Australians
por: Hensen, Luca, et al.
Publicado: (2021)

Comparison of Influenza and SIV Specific CD8 T Cell Responses in Macaques
por: Jegaskanda, Sinthujan, et al.
Publicado: (2012)

Influenza-Specific Antibody-Dependent Phagocytosis
por: Ana-Sosa-Batiz, Fernanda, et al.
Publicado: (2016)

Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection
por: Lee, Wen Shi, et al.
Publicado: (2023)

Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)
por: Sobhanie, Mahdee, et al.
Publicado: (2016)

Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients
por: Nguyen, Thi H. O., et al.
Publicado: (2021)

Performance of influenza rapid point‐of‐care tests in the detection of swine lineage A(H1N1) influenza viruses
por: Hurt, Aeron C., et al.
Publicado: (2009)

Antiviral Therapy for the Next Influenza Pandemic
por: Hurt, Aeron C.
Publicado: (2019)

Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques
por: Tan, Hyon-Xhi, et al.
Publicado: (2021)

Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin
por: Lee, Juhye M, et al.
Publicado: (2019)

Special Issue—Immunity to Influenza Viruses
por: Koutsakos, Marios, et al.
Publicado: (2022)

Mucosal vaccines for SARS-CoV-2: triumph of hope over experience
por: Pilapitiya, Devaki, et al.
Publicado: (2023)

Evidence for the Introduction, Reassortment, and Persistence of Diverse Influenza A Viruses in Antarctica
por: Hurt, Aeron C., et al.
Publicado: (2016)

Neutralizing Antibody Therapeutics for COVID-19
por: Hurt, Aeron C., et al.
Publicado: (2021)

SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses
por: Koutsakos, Marios, et al.
Publicado: (2023)

The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants
por: Koutsakos, Marios, et al.
Publicado: (2022)

Debate Regarding Oseltamivir Use for Seasonal and Pandemic Influenza
por: Hurt, Aeron C., et al.
Publicado: (2016)

SARS‐CoV‐2‐specific CD8(+) T‐cell responses and TCR signatures in the context of a prominent HLA‐A*24:02 allomorph
por: Rowntree, Louise C, et al.
Publicado: (2021)

Cross-Reactive and Lineage-Specific Single Domain Antibodies against Influenza B Hemagglutinin
por: Ramage, Walter, et al.
Publicado: (2019)

Assessment of the RNASound RNA Sampling Card for the Preservation of Influenza Virus RNA
por: Lau, Hilda, et al.
Publicado: (2016)

What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins
por: Vanderven, Hillary A., et al.
Publicado: (2016)

Using the Ferret as an Animal Model for Investigating Influenza Antiviral Effectiveness
por: Oh, Ding Y., et al.
Publicado: (2016)

A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade
por: Oh, Ding Yuan, et al.
Publicado: (2014)

High expression of CD38 and MHC class II on CD8(+) T cells during severe influenza disease reflects bystander activation and trogocytosis
por: Jia, Xiaoxiao, et al.
Publicado: (2021)

Immune Pressure on Polymorphous Influenza B Populations Results in Diverse Hemagglutinin Escape Mutants and Lineage Switching
por: Plant, Ewan P., et al.
Publicado: (2020)

Influenza hemagglutinin membrane anchor
por: Benton, Donald J., et al.
Publicado: (2018)

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
por: Leang, Sook-Kwan, et al.
Publicado: (2017)

A Review of DNA Vaccines Against Influenza
por: Lee, Leo Yi Yang, et al.
Publicado: (2018)

Immune imprinting and SARS-CoV-2 vaccine design
por: Wheatley, Adam K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aqc336mhl36iiqvrrjkdrm7p8e